Yusheng Shi

Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma

Yinghong Tian, Li Peng, Xingmei Zhang, 2020, International journal of nanomedicine.

Treatment of non-small cell lung cancer (NSCLC) using CT in combination with a PET examination to minimize the clinical target volume of the mediastinum

Long-hua Chen, Yusheng Shi, Xiao-gang Deng, 2007 .

A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.

Y. Liu, Meng Shao, Qirui Wang, 2013, Biochemical and biophysical research communications.

Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells

F. Wang, Yanling Liang, Li Peng, 2018, Molecular therapy. Nucleic acids.

The Aptamer Ob2, a novel AChE inhibitor, restores cognitive deficits and alleviates amyloidogenesis in 5×FAD transgenic mice

Xingmei Zhang, Xiaoting Luo, Zhiman Liang, 2022, Molecular therapy. Nucleic acids.

A U87-EGFRvIII cell-specific aptamer mediates small interfering RNA delivery.

Xingmei Zhang, Shuji Li, Yusheng Shi, 2014, Biomedical reports.

Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer’s Disease Cell Model

F. Wang, Xingmei Zhang, Shuji Li, 2015, PloS one.

Cell-SELEX Aptamer for Highly Specific Radionuclide Molecular Imaging of Glioblastoma In Vivo

Xingmei Zhang, Shuji Li, Yusheng Shi, 2014, PloS one.